| 2932.99.35 | 00 | 2-Hydroxy-3-dibenzofurancarboxylic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 66.5% |
| 2932.99.39 | 00 | Benzointetrahydropyranyl ester; and Xanthen-9-one | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2932.99.55 | 00 | Bis-O-[(4-methylphenyl)methylene]-D- glucitol (Dimethylbenzylidene sorbitol); and Rhodamine 2C base | kg | Free | | 15.4￠/kg + 52% |
| 2933 | | Heterocyclic compounds with nitrogen hetero-atom(s) only: | | | | |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Phenazone (Antipyrine) and its derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 49.5% |
| 2933.19.04 | 00 | Aminomethylphenylpyrazole (Phenylmethylaminopyrazole); and 3-Methyl-1-(p-tolyl)-2-pyrazolin-5-one (p-Tolyl methyl pyrazolone) | kg | Free | | 15.4￠/kg + 39.5% |
| 2933.19.08 | 00 | 3-(5-Amino-3-methyl-1H-pyrazol-1-yl)- benzenesulfonic acid; Amino-J-pyrazolone; 3-Amino-1-(2,4,6-trichlorophenyl)-5- pyrazolone; 3-Carboxy-1,4-sulfophenylpyrazol-5-one; 4-Chloro-3-(3-methyl-5-oxo-2-pyrazolin-1- yl)benzenesulfonic acid; 1-(m-Chlorophenyl)-3-methyl-2-pyrazolin- 5-one; p-Chloropyrazolone; 1-(2',5'-Dichlorophenyl)-3-methyl-2- pyrazolin-5-one; 1-(o-Ethylphenyl)-3-methyl-2-pyrazolin- 5-one; 5-Imino-3-methyl-1-phenylpyrazole; 5-Imino-3-methyl-1-(m-sulfophenyl)- pyrazole; 2,4-Methylcarboxypyrazolic acid; Methylphenylpyrazolone; and Sulfinpyrazone | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.19.15 | 00 | 1,2-Dimethyl-3,5-diphenyl-1H-pyrazolium methyl sulfate (Difenzoquat methyl sulfate) | kg | Free | | 15.4￠/kg + 48.5% |
| 2933.19.18 | 00 | 2-Chloro-5-sulfophenylmethylpyrazolone; 2,5-Dichloro-4-(3-methyl-5-oxo-2- pyrazolin-1-yl) benzenesulfonic acid; Phenylcarbethoxypyrazolone; m-Sulfaminopyrazolone (m-Sulfamido- phenylmethylpyrazolone); and 1-(p-Sulfophenyl)-3-methylpyrazolone | kg | Free | | 15.4￠/kg + 52% |
| 2933.19.70 | 00 | 3-Methyl-5-pyrazolone | kg | Free | | 30.5% |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Hydantoin and its derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 63% |
| 2933.29.05 | 00 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | kg | Free | | 15.4￠/kg + 52% |
| 2933.29.10 | 00 | 2-Phenylimidazole | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.31.00 | 00 | Pyridine and its salts | kg | Free | | Free |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.39.08 | 00 | 1-(3-Sulfopropyl)pyridinium hydroxide; N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6- hexanediamine; 3,5-Dimethyl-2-hydroxymethyl-4-methoxy- pyridine (pyrmethyl alcohol); Dipentamethylenethiuram tetrasulfide; 2H-Indol-2-one,1,3-dihydro-1-phenyl-3-(4- pyridinylmethylene); 4-Picolyl chloride hydrochloride; and Piperidinoethyl chloride hydrochloride | kg | Free | | 15.4￠/kg + 52% |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.39.31 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.49.10 | 00 | Ethoxyquin (1,2-Dihydro-6-ethoxy-2,2,4- trimethylquinoline) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 55% |
| 2933.49.15 | 00 | 8-Methylquinoline and Isoquinoline | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
